Monitoring and follow-up: NICE guideline NG28 recommends regular review of patients on GLP-1 receptor agonists, including assessment of glycaemic control, weight, renal function, and tolerability
Clinical Progress of Glutaminase Inhibitors Glutaminase inhibitors selectively target the overactive GLS in cancer cells, sparing GLS2 in normal cells: Blocking EMT (Epithelial-to-Mesenchymal Transition) : These inhibitors can help prevent EMT, which supports cancer spread
They have exploded in popularity online, with influencers suggesting they can help build muscle, improve metabolism and more
We source premium, research-backed ingredients, including patented Eriomin , PreticX , and Yestein
10.1053/j.ajkd.2013.04.007 52